Literature DB >> 1531943

1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR.

M A Meehan1, R H Kerman, J M Lemire.   

Abstract

The active vitamin D metabolite, 1,25-dihydroxyvitamin D3 (1,25-D3), has been shown in both in vitro and in vivo experiments to be immunoregulatory. We analyzed the effects of the hormone on the human mixed lymphocyte reaction (MLR), the in vitro model of allograft response. Suppressor-cell activity of MLR-generated effector cells was enhanced by calcitriol (10(-10) to 10(-8) M). This suppressor activity was nonspecific since calcitriol-generated effector cells could suppress a primary MLR with stimulators and/or responders heterologous to the effector-generating MLR. Calcitriol (10(-9) to 10(-7) M) was also effective in preventing the generation of cytotoxic T cells when tested in a 51Cr release assay. While no differences were observed in the phenotypic analyses of the MLR-generated effector cells between 1,25-D3-treated cells and control cells, a significant reduction of class II antigen expression was observed in the presence of the hormone. The effects of calcitriol on human MLR are similar to those observed with cyclosporine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531943     DOI: 10.1016/0008-8749(92)90206-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  Maternal diet vs lack of exposure to sunlight as the cause of the epidemic of asthma, allergies and other autoimmune diseases.

Authors:  Scott T Weiss; Augusto A Litonjua
Journal:  Thorax       Date:  2007-09       Impact factor: 9.139

2.  Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations.

Authors:  Rose Du; Augusto A Litonjua; Kelan G Tantisira; Jessica Lasky-Su; Shamil R Sunyaev; Barbara J Klanderman; Juan C Celedón; Lydiana Avila; Manuel E Soto-Quiros; Scott T Weiss
Journal:  J Allergy Clin Immunol       Date:  2011-11-01       Impact factor: 10.793

3.  Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality.

Authors:  Andrea B Braun; Fiona K Gibbons; Augusto A Litonjua; Edward Giovannucci; Kenneth B Christopher
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

Review 4.  Vitamin effects on the immune system: vitamins A and D take centre stage.

Authors:  J Rodrigo Mora; Makoto Iwata; Ulrich H von Andrian
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

5.  Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3.

Authors:  C Mathieu; M Waer; J Laureys; O Rutgeerts; R Bouillon
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

Review 6.  Childhood asthma may be a consequence of vitamin D deficiency.

Authors:  Augusto A Litonjua
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-06

7.  Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age.

Authors:  Carlos A Camargo; Sheryl L Rifas-Shiman; Augusto A Litonjua; Janet W Rich-Edwards; Scott T Weiss; Diane R Gold; Ken Kleinman; Matthew W Gillman
Journal:  Am J Clin Nutr       Date:  2007-03       Impact factor: 7.045

8.  1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.

Authors:  Jae-Hoon Chang; Hye-Ran Cha; Dong-Sup Lee; Kyoung Yul Seo; Mi-Na Kweon
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  The relationship between serum 25 hydroxy vitamin d levels and asthma in children.

Authors:  Soheila Alyasin; Tooba Momen; Sara Kashef; Abbass Alipour; Reza Amin
Journal:  Allergy Asthma Immunol Res       Date:  2011-07-13       Impact factor: 5.764

Review 10.  Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation.

Authors:  Sabino Scolletta; Marta Colletti; Luigi Di Luigi; Clara Crescioli
Journal:  Mediators Inflamm       Date:  2013-04-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.